BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

763 related articles for article (PubMed ID: 9309094)

  • 1. Adjuvant therapy of malignant melanoma.
    Dickler MN; Coit DG; Meyers ML
    Surg Oncol Clin N Am; 1997 Oct; 6(4):793-812. PubMed ID: 9309094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant high-dose interferon-alpha therapy for high-risk melanoma.
    Kirkwood JM; Tarhini AA
    Forum (Genova); 2003; 13(2):127-40; quiz 187-8. PubMed ID: 14732880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant therapy for malignant melanoma.
    Stoutenburg JP; Schrope B; Kaufman HL
    Expert Rev Anticancer Ther; 2004 Oct; 4(5):823-35. PubMed ID: 15485316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant interferon in high-risk melanoma: the AIM HIGH Study--United Kingdom Coordinating Committee on Cancer Research randomized study of adjuvant low-dose extended-duration interferon Alfa-2a in high-risk resected malignant melanoma.
    Hancock BW; Wheatley K; Harris S; Ives N; Harrison G; Horsman JM; Middleton MR; Thatcher N; Lorigan PC; Marsden JR; Burrows L; Gore M
    J Clin Oncol; 2004 Jan; 22(1):53-61. PubMed ID: 14665609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence-based and interdisciplinary consensus-based German guidelines: systemic medical treatment of melanoma in the adjuvant and palliative setting.
    Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R
    Melanoma Res; 2008 Apr; 18(2):152-60. PubMed ID: 18337653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant postoperative radiotherapy to the cervical lymph nodes in cutaneous melanoma: is there any benefit for high-risk patients?
    Moncrieff MD; Martin R; O'Brien CJ; Shannon KF; Clark JR; Gao K; McCarthy WM; Thompson JF
    Ann Surg Oncol; 2008 Nov; 15(11):3022-7. PubMed ID: 18958539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant therapy for melanoma.
    Sondak VK
    Cancer J; 2001; 7 Suppl 1():S24-7. PubMed ID: 11504282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Melanoma].
    Saida T
    Gan To Kagaku Ryoho; 2006 Oct; 33(10):1386-91. PubMed ID: 17033225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-risk surgically resected pediatric melanoma and adjuvant interferon therapy.
    Chao MM; Schwartz JL; Wechsler DS; Thornburg CD; Griffith KA; Williams JA
    Pediatr Blood Cancer; 2005 May; 44(5):441-8. PubMed ID: 15468307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant therapy of melanoma.
    Shah GD; Chapman PB
    Cancer J; 2007; 13(3):217-22. PubMed ID: 17620773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review of systemic adjuvant therapy for patients at high risk for recurrent melanoma.
    Verma S; Quirt I; McCready D; Bak K; Charette M; Iscoe N
    Cancer; 2006 Apr; 106(7):1431-42. PubMed ID: 16511841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidisciplinary treatment of primary melanoma.
    Yao K; Balch G; Winchester DJ
    Surg Clin North Am; 2009 Feb; 89(1):267-81, xi. PubMed ID: 19186240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cutaneous melanoma].
    Eigentler TK; Mügge LO; Bembenek A; Garbe C
    Hautarzt; 2007 Oct; 58(10):885-97; quiz 898. PubMed ID: 17973138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized adjuvant therapy trials in melanoma: surgical and systemic.
    Eggermont AM; Gore M
    Semin Oncol; 2007 Dec; 34(6):509-15. PubMed ID: 18083374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melanoma in children and the use of sentinel lymph node biopsy.
    Bütter A; Hui T; Chapdelaine J; Beaunoyer M; Flageole H; Bouchard S
    J Pediatr Surg; 2005 May; 40(5):797-800. PubMed ID: 15937817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant interferon therapy for melanoma: high-dose, low-dose, no dose, which dose?
    Schuchter LM
    J Clin Oncol; 2004 Jan; 22(1):7-10. PubMed ID: 14665612
    [No Abstract]   [Full Text] [Related]  

  • 17. Cutaneous head and neck melanoma: the old and the new.
    Rigual NR; Popat SR; Jayaprakash V; Jaggernauth W; Wong M
    Expert Rev Anticancer Ther; 2008 Mar; 8(3):403-12. PubMed ID: 18366288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase III adjuvant studies in operable malignant melanoma (review).
    Lejeune FJ
    Anticancer Res; 1987; 7(4B):701-5. PubMed ID: 3314671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial of levamisole versus placebo as adjuvant therapy in malignant melanoma.
    Spitler LE; Sagebiel R
    N Engl J Med; 1980 Nov; 303(20):1143-7. PubMed ID: 6999349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current management of melanoma: benefits of surgical staging and adjuvant therapy.
    McMasters KM; Swetter SM
    J Surg Oncol; 2003 Mar; 82(3):209-16. PubMed ID: 12619066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.